Anand Mehra insider trades: Aclaris Therapeutics (ACRS) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Anand reports to the SEC
and 9 more companies
Open-market buys and sales
41 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 19, 2024 | ACRS | ↑ Buy | 666,666 | $2.25 | $1.5M | Direct | Nov 20, 2024 (1d) |
| Nov 15, 2019 | NXTC | ↑ Buy | 150,000 | $36.75 | $5.5M | Direct | Nov 19, 2019 (4d) |
| Nov 12, 2019 | GRTX | ↑ Buy | 750,000 | $12.00 | $9.0M | Direct | Nov 12, 2019 (0d) |
| May 13, 2019 | NXTC | ↑ Buy | 400,000 | $15.00 | $6.0M | Direct | May 15, 2019 (2d) |
| Oct 22, 2018 | ACRS | ↑ Buy | 372,093 | $10.75 | $4.0M | Indirect | Oct 23, 2018 (1d) |
| Sep 28, 2018 | ETTX | ↑ Buy | 337,724 | $15.00 | $5.1M | Direct | Oct 2, 2018 (4d) |
| Sep 18, 2018 | PRNB | ↑ Buy | 270,000 | $17.00 | $4.6M | Direct | Sep 20, 2018 (2d) |
| May 30, 2018 | ITRM | ↑ Buy | 500,000 | $13.00 | $6.5M | Direct | May 30, 2018 (0d) |
| Jul 24, 2017 | ONCE | ↓ Sell | 211,858 | $70.15 | $14.9M | Indirect | Jul 26, 2017 (2d) |
| Jun 21, 2017 | ONCE | ↓ Sell | 6,302 | $65.00 | $410K | Indirect | Jun 22, 2017 (1d) |
| Mar 2, 2017 | ONCE | ↓ Sell | 15,275 | $65.01 | $993K | Indirect | Mar 6, 2017 (4d) |
| Mar 1, 2017 | ONCE | ↓ Sell | 84,654 | $65.02 | $5.5M | Indirect | Mar 1, 2017 (0d) |
| Feb 17, 2017 | ONCE | ↓ Sell | 7,535 | $65.01 | $490K | Indirect | Feb 22, 2017 (5d) |
| Feb 16, 2017 | ONCE | ↓ Sell | 35,347 | $65.03 | $2.3M | Indirect | Feb 16, 2017 (0d) |
| Feb 9, 2017 | ONCE | ↓ Sell | 37,411 | $65.06 | $2.4M | Indirect | Feb 13, 2017 (4d) |
| Feb 7, 2017 | ONCE | ↓ Sell | 25,334 | $65.06 | $1.6M | Indirect | Feb 7, 2017 (0d) |
| Jan 10, 2017 | ACRS | ↓ Sell | 750,000 | $28.25 | $21.2M | By Funds | Jan 12, 2017 (2d) |
| Dec 16, 2016 | ONCE | ↓ Sell | 349,656 | $53.46 | $18.7M | Indirect | Dec 19, 2016 (3d) |
| Dec 13, 2016 | ONCE | ↓ Sell | 122,532 | $55.17 | $6.8M | Indirect | Dec 13, 2016 (0d) |
| Oct 20, 2016 | MRNS | ↓ Sell | 750,683 | $1.39 | $1.0M | Indirect | Oct 24, 2016 (4d) |
| Aug 11, 2016 | ONCE | ↓ Sell | 29,963 | $60.13 | $1.8M | Indirect | Aug 12, 2016 (1d) |
| Aug 8, 2016 | ONCE | ↓ Sell | 100 | $60.47 | $6K | Indirect | Aug 10, 2016 (2d) |
| Aug 4, 2016 | ONCE | ↓ Sell | 5,064 | $60.00 | $304K | Indirect | Aug 5, 2016 (1d) |
| Aug 1, 2016 | ONCE | ↓ Sell | 22,665 | $60.03 | $1.4M | Indirect | Aug 3, 2016 (2d) |
| May 31, 2016 | ONCE | ↓ Sell | 500 | $60.00 | $30K | Indirect | Jun 2, 2016 (2d) |
| Nov 27, 2015 | ONCE | ↓ Sell | 22,961 | $60.01 | $1.4M | Indirect | Nov 30, 2015 (3d) |
| Nov 12, 2015 | ONCE | ↓ Sell | 130,605 | $60.11 | $7.9M | Indirect | Nov 12, 2015 (0d) |
| Oct 13, 2015 | ACRS | ↑ Buy | 409,090 | $11.00 | $4.5M | By Funds | Oct 13, 2015 (0d) |
| Oct 8, 2015 | ONCE | ↓ Sell | 529,544 | $45.46 | $24.1M | Indirect | Oct 9, 2015 (1d) |
| Oct 6, 2015 | MIRN | ↑ Buy | 857,142 | $7.00 | $6.0M | Direct | Oct 6, 2015 (0d) |
| May 12, 2015 | LIFE | ↑ Buy | 320,000 | $14.00 | $4.5M | Direct | May 14, 2015 (2d) |
| Apr 15, 2015 | AERI | ↓ Sell | 425,000 | $33.64 | $14.3M | Indirect | Apr 16, 2015 (1d) |
| Feb 4, 2015 | ONCE | ↑ Buy | 225,000 | $23.00 | $5.2M | Indirect | Feb 6, 2015 (2d) |
| Dec 8, 2014 | HSGX | ↑ Buy | 500,198 | $11.00 | $5.5M | Indirect | Dec 10, 2014 (2d) |
| Dec 8, 2014 | HSGX | ↓ Sell | 1,002 | $11.00 | $11K | Indirect | Dec 10, 2014 (2d) |
| Nov 25, 2014 | AERI | ↓ Sell | 800,000 | $26.00 | $20.8M | Indirect | Nov 26, 2014 (1d) |
| Aug 5, 2014 | MRNS | ↑ Buy | 750,683 | $8.00 | $6.0M | Indirect | Aug 7, 2014 (2d) |
| Jul 10, 2014 | AERI | ↓ Sell | 1,008,022 | $24.02 | $24.2M | Indirect | Jul 11, 2014 (1d) |
| May 22, 2014 | AERI | ↓ Sell | 323,932 | $16.00 | $5.2M | Indirect | May 27, 2014 (5d) |
| Mar 26, 2014 | VSAR | ↑ Buy | 60,000 | $21.00 | $1.3M | Direct | Mar 28, 2014 (2d) |
| Oct 25, 2013 | AERI | ↑ Buy | 285,000 | $10.00 | $2.9M | Indirect | Oct 30, 2013 (5d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other ACRS insiders
Open-market trades in the last 12 months
About Anand Mehra's insider trades
Anand Mehra is an insider at Aclaris Therapeutics (ACRS). Since Oct 25, 2013, Anand has reported 16 open-market purchases worth $77.9M and 25 sales worth $177.6M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (27 filings), conversions (14 filings), option exercises (13 filings), other transactions (7 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ACRS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.